Building Biotechs

From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.

Building Biotechs is a science podcast hosted by Recruitomics Consulting, with 57 episodes on record and a Required Pod Score of 81. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Recruitomics Consulting hosts Building Biotechs, a science show with 57 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #56

  Putting the “Tech” in Biotech: An Unconventional Path to Building a Therapeutics Company, with Federico Paoletti, PhD

  Oct 1, 202543 minS0

  <p>Federico Paoletti, co-founder of Exogene, founded his biotech company immediately after finishing his PhD, which led to a steep learning curve and many valuable lessons he now shares with other founders. He and his co-founder learned to operate like a tech startup inside biotech: validate the market before the product, iterate fast, and let customer discovery shape the platform thesis. He shares how a tough SF fundraising trip reframed their pitch from an asset-only story to a bigger, platform-driven vision that fits the right investor audience. We dig into non-dilutive funding tactics, using a success-fee grant writer, building a...

  ListenShow Notes
• 

  Episode #55

  Accelerating Drug Development is a Moral Imperative with Dr. Gabi Hanna, MD

  Sep 3, 202538 minS0

  <p>For our first episode of season three, I sat down with  Gabi Hanna, MD, CEO and co-founder of Lamassu Biotech, where he leads the development of innovative therapies for cancer and inflammatory diseases. A physician-scientist and serial entrepreneur, Dr. Hanna previously founded the first academic drug development center at Duke University and has authored over 50 peer-reviewed publications. Under his leadership, Lamassu is advancing two novel therapeutics—RABI-767, now in Phase II trial, and SA53, a first-in-class oncology compound currently in Phase I/II trial. He also oversees Lamassu Pets, which is developing a canine therapy for pancreatitis. Dr. Hanna’s wor...

  ListenShow Notes
• 

  Episode #54

  Biotech, Blockchain, and Building Companies with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners

  Dec 11, 202434 minS0

  <p>This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on...

  ListenShow Notes
• 

  Episode #53

  Funding, Partnerships, and Growth: Strategies for Startup Biotech Success with Fractional Chief Business Officer Renee Williams

  Nov 20, 202435 minS0

  <p>This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success.</p>Get Renee's recommended book! The 3-Minute...

  ListenShow Notes
• 

  Episode #52

  Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics

  Nov 8, 202438 minS0

  <p>This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her...

  ListenShow Notes

Recent guests on Building Biotechs. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.